Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Magdalena Olszewska-Szopa, Agnieszka Ożańska, Tomasz Ożański, Justyna Rybka & Tomasz Wróbel. (2024) The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience. Leukemia & Lymphoma 65:1, pages 55-61.
Read now
Read now
Patrick Cobb, Dietger Niederwieser, Stanley Cohen, Caroline Hamm, Gerd Burmester, Neungseon Seo, Sonya G Lehto & Vladimir Hanes. (2022) A Review of the Totality of Evidence in the Development of ABP 798, A Rituximab Biosimilar. Immunotherapy 14:9, pages 727-740.
Read now
Read now
Ahmed Shelbaya, John M Kelton, Jeffrey Thompson, Jose MJ Alvir, Martine C Maculaitis & Jingyan Yang. (2021) Real-World Use and Acceptance of Biosimilar Monoclonal Antibodies of Rituximab in Oncology Practice in the USA. Future Oncology 17:30, pages 3941-3950.
Read now
Read now
Articles from other publishers (6)
Reena Nair, Gull Mohammad Bhat, Narendra Agrawal, Manju Sengar, Pankaj Malhotra, Soniya Nityanand, Chitra Lele, Pramod Reddy, Suresh Kankanwadi & Narendra Maharaj. (2023) Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era. Frontiers in Oncology 13.
Crossref
Crossref
Benjamin Greenberg & Gavin Giovannoni. (2023) A place for biosimilars in the changing multiple sclerosis treatment landscape. Multiple Sclerosis and Related Disorders 77, pages 104841.
Crossref
Crossref
Hugo Jourdain, Léa Hoisnard, Emilie Sbidian & Mahmoud Zureik. (2023) Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System. BioDrugs 37:3, pages 397-407.
Crossref
Crossref
María Elena Cabrera, Camila Peña, Pilar Leon, Vivianne Lois, Hernán Rojas, Valeska Vega, Alvaro Pizarro, Susana Calderon, Christine Rojas, Augusto Aspillaga, M. Luisa Gonzalez, Marvila Intriago, Bernardita Rojas, Cecilia Hales, Jacqueline Oliva, Mónica Romero, Marisa Capurro & Jorge J. Castillo. (2022) Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System. JCO Global Oncology:8.
Crossref
Crossref
Simon Cheesman. (2021) Introduction of Biosimilar Rituximab: A Hospital Perspective. HemaSphere 5:1, pages e515.
Crossref
Crossref
Viktoriya Pavlych, Claudia Di Muzio, Alessia Alunno & Francesco Carubbi. (2020) Comparison of Rituximab Originator With CT-P10 Biosimilar in Patients With Primary Sjögren's Syndrome: A Retrospective Analysis in a Real-Life Setting. Frontiers in Medicine 7.
Crossref
Crossref